About: National Cancer Center Hospital East

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: National Cancer Center Hospital East Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

healthcare organization in Kashiwa, Japan

Attributes	Values
rdf:type	Item
description	griya sakit (jv) rumah sakik (min) rumoh sakét (ace) hospital di Jepun (ms) rumah sakit di Jepang (id) জাপানের একটি হাসপাতাল (bn) Krankenhaus in Japan (de) مستشفى في كاشيوا، تشيبا، اليابان (ar) healthcare organization in Kashiwa, Japan (en)
rdfs:label	National Cancer Center Hospital East (en) 国立がん研究センター東病院 (ja)
skos:prefLabel	National Cancer Center Hospital East (en) 国立がん研究センター東病院 (ja)
name	National Cancer Center Hospital East (en) 国立がん研究センター東病院 (ja)
ROR ID	wds:Q55454195-F1EA4C32-F126-49E4-8267-B5A45B16C76F
ROR ID	03rm3gk43
instance of	wds:Q55454195-BF184944-E16D-4537-9F8C-D6D9FA021774 wds:Q55454195-E152397F-5B79-4328-A815-CA82D7859382
instance of	hospital medical organization
country	wds:Q55454195-9572D020-8E45-4D30-88E1-1C46116EFE10
country	Japan
inception	wds:Q55454195-CACECCDA-FB80-4320-B4C9-8335E7E152B1
inception	1962-01-01 00:00:00Z (xsd:dateTime)
Commons category	wds:Q55454195-a7ff9291-8270-4f13-9a4c-36ed3ae54904
Commons category	National Cancer Center Hospital East
OpenStreetMap node ID	wds:Q55454195-C41A849E-8338-47DE-901B-44F4CC4235EC
located in the adm...erritorial entity	wds:Q55454195-9dbccaaa-4161-b263-dfe3-2ae1ad51d634
VIAF ID	wds:Q55454195-8602DECB-56AD-46E0-8902-5A06C26E0CFC
coordinate location	wds:Q55454195-35299ECF-659B-4F59-9576-03CA7A7FF214
WorldCat Identities ID (superseded)	wds:Q55454195-DE340475-3D97-43AC-982C-0A3FD1ACC726
official website	wds:Q55454195-F9451677-3553-4181-9A24-56BCA019A4D9
VIAF ID	http://viaf.org/viaf/255635414
OpenStreetMap node ID	1420731029
located in the adm...erritorial entity	Kashiwa
VIAF ID	255635414
coordinate location	POINT(139.941547 35.902275)
WorldCat Identities ID (superseded)	viaf-255635414
official website	https://www.ncc.go.jp/en/ncce/index.html
GRID ID	wds:Q55454195-DD1D2417-4E12-40A7-89D1-9250FB568872
GRID ID	grid.497282.2
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q55454195 Category:National Cancer Center Hospital East
is research site of	Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Safety and Efficacy of One Dose Prophylactic Antibiotic in Laparoscopic Colorectal Surgery BBI608 and Best Supportive Care vs Placebo and Best Supportive Care in Patients With Pretreated Advanced Colorectal Carcinoma DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01] A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200) A Trial to Evaluate Para-aortic Lymphadenectomy for Gastric Cancer An Open-Label, Single Arm Study of Obinutuzumab Short Duration Infusion in Patients With Previously Untreated Advanced Follicular Lymphoma Study of DS-8201a for Participants With Advanced Solid Malignant Tumors Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2) Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200) Safety Study of HBI-8000 in Japanese Patients With Non Hodgkin's Lymphoma A Study Of Oral Palbociclib (PD-0332991), A CDK4/6 Inhibitor, As Single Agent In Japanese Patients With Advanced Solid Tumors Or In Combination With Letrozole For The First-Line Treatment Of Postmenopausal Japanese Patients With ER (+) HER2 (-) Study of the Safety and Activity of Lenvatinib (E7080) in Subjects With KIF5B-RET-Positive Adenocarcinoma of the Lung Study of NPC-07 for Fluorescence-guided Resection of Malignant Gliomas A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer A Study of PD-L1 Antibody KN035 in Japanese Subjects With Locally Advanced or Metastatic Solid Tumors An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100) Patritumab Deruxtecan in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer A Study to Test Different Doses of BI 765063 Alone and in Combination With BI 754091 in Japanese Patients With Different Types of Advanced Cancer (Solid Tumors) Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy GEN1046 Safety and PK in Subjects With Advanced Solid Malignancies A Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic Non-small Cell Lung Cancer Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer A Study of TAK-659 as a Single Agent in Adult East Asian Participants With Non-Hodgkin Lymphoma (NHL) Study of TBI-1301 (NY-ESO-1 T Cell Receptor Gene Transduced Autologous T Lymphocytes) in Patients With Synovial Sarcoma Phase 2 Study of KHK2375 in Subjects With Advanced or Recurrent Breast Cancer A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer Elderly NSCLC/D vs DP (JCOG0207) Study of REGN2810 in Adults With Cervical Cancer Phase 1 Study of CC-486 in Japanese Subjects With Hematological Neoplasms First-in-human Study of ATR Inhibitor BAY1895344 in Patients With Advanced Solid Tumors and Lymphomas Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK) A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer Phase 2 Study of Brigatinib in Japanese Patients With ALK-Positive Non-Small Cell Lung Cancer (NSCLC) Phase I/II Clinical Study of Pralatrexate in Japanese Patients With Relapsed or Refractory Peripheral T-cell Lymphoma To Assess the Safety and Tolerability of Tafasitamab Alone or in Combination With Other Drugs in Japanese Participants With Non-Hodgkins Lymphoma (NHL) Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-04/ECHO-305-04) A Study of RO5137382 (GC33) in Patients With Advanced or Metastatic Hepatocellular Carcinoma Phase II of BAX2398/5-FU/Calcium Levofolinate in Pancreatic Cancer A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130) DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing or -Mutated Non-Small Cell Lung Cancer PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15 A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell Lymphoma Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software